Search clinical trials for: Dasatinib, Mitoxantrone, Cytarabine

Total 2815 results

Fujian Medical University

Recruiting

A Study of TAE+HAIC Combined With Camrelizumab and Apatinib in the Treatment of Advanced Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma

China
Qingdao Central Hospital

Recruiting

Phase II Study of Afatinib Plus Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon G719X, S768I, and L861Q Mutation Metastatic Non-Small Cell Lung Cancer

PFS

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Food Effect Study of Apatinib Mesylate in Healthy Subjects

Healthy Subjects

China
Sichuan Cancer Hospital and Research Institute

Unknown

Efficacy and Safety of Apatinib As Third Line Therapy in Patients With Advanced Ovarian Cancer

Angiogenesis Inhibitors，Ovarian Neoplasms

China
Sun Yat-sen University

Unknown

Apatinib in the Treatment of Advanced Non-squamous Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Beijing Sanbo Brain Hospital

Recruiting

Apatinib in the Treatment of Recurrent Atypical/Malignant Meningioma in Adults

Recurrent Atypical/Malignant Meningioma

China
Affiliated Hospital of Qinghai University

Completed

Apatinib for the Elderly Advanced Gastric Cancer

Gastric Cancer

China
The Affiliated Hospital of Qingdao University

Unknown

The Combination of Apatinib and Camerlizumab for Advanced Lung Cancer Patients With Muti-line Therapy

Lung Cancer

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study to Evaluate the Pharmacokinetics of Apatinib in Subjects With Impaired Renal Function

Subjects With Impaired Renal Function and Healthy Subjects
Jiangsu HengRui Medicine Co., Ltd.
Fudan University; The 81 Hospital of PLA

Completed

Phase III Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer

Advanced or Metastatic Gastric Cancer

China
AB Science

Completed

Efficacy of Oral AB1010 in Adult Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis
NCIC Clinical Trials Group
Bayer

Completed

Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Myelodysplastic Syndromes | Leukemia

Canada
National Center for Research Resources (NCRR)
University of Michigan

Completed

Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus

Lupus Erythematosus, Systemic
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib and Fluzoparib in Patients With TNBC

Triple Negative Breast Cancer

China
Novartis Pharmaceuticals

Completed

Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer

Neoplasms, Breast

Spain, Canada, United States, Australia, Austria, Italy, Japan, Poland, Sweden, France, Germany, Switzerland, Taiwan, United Kingdom, Belgium, Greece, India
GlaxoSmithKline

Completed

Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer Patients

Carcinoma, Renal Cell

United States, Netherlands
GlaxoSmithKline

Completed

Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer

Neoplasms, Breast

United States, Canada, Germany, Spain, Taiwan, Belgium, Philippines, Israel, Hong Kong, Thailand, Pakistan, Russian Federation, Italy, Romania, China, France, Peru, United Kingdom, Czech Republic, Australia, Chile, Korea, Republic of and more
European Organisation for Research and Treatment...
GlaxoSmithKline

Completed

Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer

Breast Cancer

France, United Kingdom, Belgium, Switzerland, Slovenia
Sun Yat-sen University
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab Versus Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification (TRIPLET-III)

C-staged Hepatocellular Carcinoma in BCLC Classification

China
Milton S. Hershey Medical Center

Terminated

Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias

Leukemia

United States
Institut Paoli-Calmettes

Not yet recruiting

Evaluation of DASATINIB Monotherapy Efficacy in Acute Myeloid Leukemia Patients Refractory to VENETOCLAX-AZACITIDINE (VEN-R DASA)

Acute Myeloid Leukemia
University Health Network, Toronto
Ozmosis Research Inc.

Unknown

Treatment-free Remission Accomplished With Dasatinib in Patients With CML (TRAD)

Chronic Myeloid Leukemia

Canada
University of Virginia

Completed

Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer

Endometrial Cancer

United States
Bristol-Myers Squibb
Children's Oncology Group; EsPhALL

Completed

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Leukemia, Pediatric

United States, Canada, United Kingdom, Italy, Australia, Puerto Rico
Duke University
Bristol-Myers Squibb

Terminated

Phase II Study of Dasatinib in Previously Treated Patients With Advanced NSCLC (TOP0801)

Non Small Cell Lung Cancer

United States
Bristol-Myers Squibb

Withdrawn

Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL

Acute Lymphoblastic Leukemia | Chronic Myeloid Leukemia

Netherlands, Italy, United Kingdom, Russian Federation, Poland, Hungary
Bristol-Myers Squibb

Completed

BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia

Leukemia, Lymphoblastic, Acute, Philadelphia-positive | Leukemia, Myeloid, Chronic-phase

United States
Bristol-Myers Squibb

Completed

Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan

Chronic Myelogenous Leukemia

Japan
Vion Pharmaceuticals

Completed

Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia

Leukemia

France, Canada, Greece, United States, Belgium, Netherlands, United Kingdom, Germany, Poland, Serbia
Wuhan Union Hospital, China

Not yet recruiting

Tucidinostat Plus Apatinib for Advanced Osteosarcoma

Osteosarcoma
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Preoperative IMRT With Concurrent Apatinib for Localised Extremity or Trunk Sarcoma

Sarcoma,Soft Tissue | Trunk | Extremity | Intensity-modulated Radiotherapy | Major Wound Complications | Targetd Therapy

China
Yuhong Li

Completed

Apatinib for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment (Poetry-1)

Esophageal Squamous Cell Carcinoma

China
Fan Yun, MD

Completed

Apatinib for Extensive Stage Small Cell Lung Cancer After Second/Third Line Chemotherapy.

Small Cell Lung Cancer

China
First Affiliated Hospital of Harbin Medical University

Terminated

Clinical Study of Apatinib in the Treatment of Platinum Resistant Recurrent Ovarian Cancer

Ovarian Cancer

China
The First Affiliated Hospital with Nanjing Medical...
Jiangsu HengRui Medicine Co., Ltd.; Beijing gene plus technology co., LTD

Completed

Apatinib in Refractory Colorectal Cancer

Colorectal Neoplasms

China
Shanghai Ninth People's Hospital Affiliated to...

Unknown

A Study of Apatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck

Adenoid Cystic Carcinoma

China
Boehringer Ingelheim

Completed

Long-term Observation PMS for Afatinib

Carcinoma, Non-Small-Cell Lung

Japan
Shanghai Ninth People's Hospital Affiliated to...

Unknown

Radiotherapy Concurrent With Apatinib in Advanced Soft Tissue and Bone Sarcomas of Head and Neck--RASS Study (RASS)

Sarcoma | Head and Neck Cancer | Soft Tissue and Bone Tumor

China
Jiangsu HengRui Medicine Co., Ltd.
Sun Yat-sen University

Completed

A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer

Non-Small-Cell Lung Cancer

China
Fudan University

Completed

Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer

Gastric Carcinoma

China
Sun Yat-sen University
CSPC Ouyi Pharmaceutical Co., Ltd.

Recruiting

Phase I Dose Escalation and Pharmacokinetics Clinical Trial of Mitoxantrone Hydrochloride Liposome in Children With Relapsed and Refractory Lymphoma and Solid Tumors

Pediatric Solid Tumor

China
Robert Redner, MD
Pfizer

Active, not recruiting

Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy

Acute Myeloid Leukemia

United States
Oshadi Drug Administration

Suspended

Oshadi D & Oshadi R Combined With Salvage Chemotherapy for Relapsed Acute Myeloid Leukemia or Lymphoid Leukemia Patients

Acute Myeloid Leukemia | Lymphoid Leukemia
Fujian Cancer Hospital

Not yet recruiting

Fluzopari Combined With Apatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer

Ovarian Cancer

China
Fudan University

Recruiting

Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer

Gastric Cancer | Metastasis

China
Di Wu

Recruiting

Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma

Acral Melanoma

China
Peking University People's Hospital

Completed

Apatinib for Inoperable Advanced Chondrosarcoma (AIAC)

Efficacy | Toxicity, Drug

China
Guangzhou Institute of Respiratory Disease
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Efficacy and Safety of Apatinib as Third-line Therapy for Primary Pulmonary Lymphoepithelioid Carcinoma (Spark-AL003)

Lung Carcinoma

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)

Small Cell Lung Cancer

China
Tianjin Medical University Cancer Institute and...

Unknown

Phase 2 Trial of Apatinib Mesylate in Locally Advanced/Metastatic Differentiated Thyroid Carcinoma

Differentiated Thyroid Carcinoma

China

Search clinical trials for: Dasatinib, Mitoxantrone, Cytarabine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations